Zhu Theodore
Known title: DirectorCIK: 0002133026
Zhu Theodore's purchase track record
Zhu Theodore has no open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 9/8/2026 | AGPU | $98K | pending | pending | — |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Transaction History
| AGPU | ▲ Buy | Grant | 733 | $0 | 10/1/2026 | View on chart |
| AGPU | ▲ Buy | Open Market | 5,000 | $54K | 9/8/2026 | View on chart |
| AGPU | ▲ Buy | Open Market | 3,750 | $44K | 9/8/2026 | View on chart |
| AGPU | ▲ Buy | Grant | 2,420 | $0 | 7/1/2026 | View on chart |
| AGPU | ▲ Buy | Grant | 11,250 | $74K | 5/29/2026 | View on chart |
| AGPU | ▲ Buy | Grant | 3,750 | $25K | 5/28/2026 | View on chart |
| AGPU | ▲ Buy | Grant | 5,144 | $0 | 4/20/2026 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
Axe Compute Signs $266M in AI Contracts, Exits Cancer Business
Axe Compute has secured over $266 million in new AI infrastructure contracts since mid-August. The company is also selling its cancer business to fully transition into an AI-focused entity. These moves mark a significant strategic shift for the stock, which trades with high beta and has a wide 52-week range.
Axe Compute Signs $266M in AI Contracts, Exits Cancer Business. Axe Compute has secured over $266 million in new AI infrastructure contracts since mid-August. The company is also selling its cancer business to fully transition into an AI-focused entity. These moves mark a significant strategic shift for the stock, which trades with high beta and has a wide 52-week range.